[HTML][HTML] The role of collagen in cancer: from bench to bedside

S Xu, H Xu, W Wang, S Li, H Li, T Li, W Zhang… - Journal of translational …, 2019 - Springer
Collagen is the major component of the tumor microenvironment and participates in cancer
fibrosis. Collagen biosynthesis can be regulated by cancer cells through mutated genes …

[HTML][HTML] Quiescent cancer cells—a potential therapeutic target to overcome tumor resistance and relapse

E Lindell, L Zhong, X Zhang - International Journal of Molecular Sciences, 2023 - mdpi.com
Quiescent cancer cells (QCCs) are nonproliferating cells arrested in the G0 phase,
characterized by ki67low and p27high. QCCs avoid most chemotherapies, and some …

[HTML][HTML] c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis

YC Feng, XY Liu, L Teng, Q Ji, Y Wu, JM Li… - Nature …, 2020 - nature.com
The functions of the proto-oncoprotein c-Myc and the tumor suppressor p53 in controlling
cell survival and proliferation are inextricably linked as “Yin and Yang” partners in normal …

[HTML][HTML] Visualization of endogenous p27 and Ki67 reveals the importance of a c-Myc-driven metabolic switch in promoting survival of quiescent cancer cells

T La, S Chen, T Guo, XH Zhao, L Teng, D Li… - Theranostics, 2021 - ncbi.nlm.nih.gov
Rationale: Recurrent and metastatic cancers often undergo a period of dormancy, which is
closely associated with cellular quiescence, a state whereby cells exit the cell cycle and are …

Regulatory role of quiescence in the biological function of cancer stem cells

SH Lee, T Reed-Newman, S Anant… - Stem Cell Reviews and …, 2020 - Springer
Quiescence in cancer cells is considered a therapeutic challenge as it confers dormancy in
tumour, hence circumventing inherent anti-neoplastic surveillance system and standard-of …

Non-coding RNAs, guardians of the p53 galaxy

S Chen, RF Thorne, XD Zhang, M Wu, L Liu - Seminars in cancer biology, 2021 - Elsevier
The TP53 gene is arguably the most important tumor suppressor gene known, contributing
multifaceted roles to the process of tumor development. Its protein product p53, is a crucial …

[HTML][HTML] CKS1B as drug resistance-Inducing gene—a potential target to improve cancer therapy

W Shi, Q Huang, J Xie, H Wang, X Yu, Y Zhou - Frontiers in Oncology, 2020 - frontiersin.org
Cancer is a threat to human health and life. Although previously centered on chemical drug
treatments, cancer treatment has entered an era of precision targeted therapy. Targeted …

[HTML][HTML] miRNome profiling of lung cancer metastases revealed a key role for miRNA-PD-L1 axis in the modulation of chemotherapy response

R Cuttano, T Colangelo, J Guarize, E Dama… - Journal of Hematology & …, 2022 - Springer
Locally advanced non-small cell lung cancer (NSCLC) is frequent at diagnosis and requires
multimodal treatment approaches. Neoadjuvant chemotherapy (NACT) followed by surgery …

A novel pipeline for prioritizing cancer type‐specific therapeutic vulnerabilities using DepMap identifies PAK2 as a target in head and neck squamous cell carcinomas

MK Sannigrahi, AC Cao, P Rajagopalan… - Molecular …, 2024 - Wiley Online Library
There is limited guidance on exploiting the genome‐wide loss‐of‐function CRISPR screens
in cancer Dependency Map (DepMap) to identify new targets for individual cancer types …

[HTML][HTML] Emerging roles of microRNAs in the regulation of Toll-like receptor (TLR)-signaling

S Banerjee, WE Thompson… - Frontiers in bioscience …, 2021 - ncbi.nlm.nih.gov
Toll-like receptors (TLRs) are evolutionarily conserved molecules that detect exogenous and
endogenous molecular patterns and trigger both the innate and adaptive immune systems to …